From May 31 to June 1, “the Seminar for the New Progress in Viral Hepatitis and Liver Disease”, one of the National Continuing Education Program jointly sponsored by the Chinese Medical Association Training Department and Peking University First Hospital and supported by the Infectious Diseases Hospital in Qingdao, was held as scheduled in Qingdao. More than 200 participants from various regions of the country attended the seminar.
Hosted by Professor Guiqiang Wang, the Director of Infectious Disease Department of Peking University First Hospital, and the Vice Chairman of the Infection Disease Branch of Chinese Medical Association, the seminar invited other domestic famous experts to comprehensively and systematically introduce the latest progress of viral hepatitis and liver disease.
During the seminar, Professor Guiqiang Wang and Professor FengqinHou presented the clinical research and application results of Ursofalk in viral hepatitis and autoimmune hepatitis in detail and also actively promoted the positive therapy of Ursofalk in internal medical department.
“The Seminar for the New Progress in Viral Hepatitis and Liver Disease” is a high-level academic seminar in domestic infectious disease departments. Since its launch, the seminar has been held successfully for two years with ten courses at total.
The seminar is to be held for four courses this year in Qing dao, Xi∮an, Harbin and Shijiazhuang respectively.